Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease
European Journal of Gastroenterology & Hepatology | Feb 16, 2018
Viral drug resistance through 48 weeks, in a phase 2b, randomized, controlled trial of the HIV-1 attachment inhibitor prodrug, fostemsavir
Journal of Acquired Immune Deficiency Syndromes | Feb 15, 2018
Smoking is not associated with higher prevalence of JC virus in MS patients
European Journal of Clinical Microbiology & Infectious Diseases | Feb 14, 2018
Most read this week